Update Page….COMING SOON

Posted 11/09/2004.

Clinical notes – Forth coming.

During the first 2 months of the basal insulin graph and during the first antibiotic course. I removed all dairy from my diet.

October 2004: Acting on a tip I received from Dr. Schnitzer, a leading diabetes expert about sinus inflammation, cow’s milk, and mucus production; I then removed all dairy from my diet again. During the first two weeks my nose dried up and I could feel the inflammation shrinking, then I became hypoglycemic and had to reduce my Lantus® insulin regularly. Now after 3 weeks I am using 40 units less Lantus® insulin than when I started. A savings of $60. a month which I have to pay out of pocket. I believe that a non-insulin dependent diabetic would have been cured by this alone.

My Letter to all national and state elected officials

Permission is granted to obtain copies of my letter directly from your Congressional, State Representative, or Governor’s office. It’s a matter of public record. Some states such as Florida will grant such requests to the public and the media, should your state’s laws be more restrictive. The information I passed along is the same.

In October/November of 2003, I informed every chapter of the American Diabetes Association and the Juvenile Diabetes Research Foundation about the issue of C-Peptide testing. None have shown any interest in this matter, and to date they continue to mislead diabetics about this issue. They continue to raise money for diabetes research to “find a cure” despite the fact that I informed them again in 2004 on just how to accomplish “a cure”.

They showed no interest.

Observations from Canada:

Humalog® insulin 10 mL vials are available without a prescription at retail pharmacies in Canada.

The retail price for a Humalog® insulin 10mL vial in Canada is Canadian $31.99 or approx. U.S. $24.00.

The retail pharmacy price for Humalog® in the United States is $88.00.

The price paid by insurance companies for Humalog® through a U.S. mail order pharmacy is $60.00.

Mail order pharmacies in the U.S. do not offer the benefit of lower prices to non-insured or “self-pay” customers.

How good it makes me feel to know that Eli Lilly & Company, a U.S. corporation offers its products to U.S. residents at more than 3 times the price that it offers the same products to residents of foreign countries. And that many diabetic U.S. residents do not have health insurance, while all diabetic Canadians have health insurance and do not pay for medications out of pocket.

Eli Lilly & Company – Indianapolis, Indiana U.S.A. (maker of Humalog® insulin) seems to have an insulin monopoly in Canada.

Lantus® insulin (Aventis Pharmaceuticals) is not available in Canada.

November 09, 2004: Letter from Health Canada

Dear Mr. Tubiana:

Thank you for your correspondence of September 7, 2004, addressed to the Honourable Ujjal Dosanjh, Minister of Health, concerning the availability of Lantus® (insulin glargine) in Canada. I regret the delay in responding.

I am pleased to inform you that Lantus®, manufactured by Aventis Pharma Inc., is approved in Canada. A Notice of Compliance was issued by Health Canada on April 3, 2002. However, the date of Health Canada's approval does not necessarily correspond to the date the product is launched on the Canadian market. For various reasons, the manufacturer may not launch the product immediately upon approval. For questions regarding market availability, you may wish to contact Aventis Pharma Canada directly at 1-800-363-6364, or by e-mail at cainternet@aventis.com.

Again, thank you writing.

Yours sincerely,

Executive Correspondence Directorate

I greatly sympathize with diabetics in Canada who do not yet have the benefit of improved quality of life that Lantus® insulin offers.

HOME